The Canadian Cardiovascular Society has issued updated guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease (CV) in adults. The new guidelines place more emphasis on data obtained from clinical trials with CV outcome data and less emphasis on trials with results based on biomarkers or surrogate endpoints.
Originally published in the October 20, 2009, issue of The Link
